• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空间分辨转录组学揭示弥漫性大 B 细胞淋巴瘤中巨噬细胞的异质性和预后意义。

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma.

机构信息

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, PR China.

出版信息

Nat Commun. 2024 Mar 8;15(1):2113. doi: 10.1038/s41467-024-46220-z.

DOI:10.1038/s41467-024-46220-z
PMID:38459052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10923916/
Abstract

Macrophages are abundant immune cells in the microenvironment of diffuse large B-cell lymphoma (DLBCL). Macrophage estimation by immunohistochemistry shows varying prognostic significance across studies in DLBCL, and does not provide a comprehensive analysis of macrophage subtypes. Here, using digital spatial profiling with whole transcriptome analysis of CD68+ cells, we characterize macrophages in distinct spatial niches of reactive lymphoid tissues (RLTs) and DLBCL. We reveal transcriptomic differences between macrophages within RLTs (light zone /dark zone, germinal center/ interfollicular), and between disease states (RLTs/ DLBCL), which we then use to generate six spatially-derived macrophage signatures (MacroSigs). We proceed to interrogate these MacroSigs in macrophage and DLBCL single-cell RNA-sequencing datasets, and in gene-expression data from multiple DLBCL cohorts. We show that specific MacroSigs are associated with cell-of-origin subtypes and overall survival in DLBCL. This study provides a spatially-resolved whole-transcriptome atlas of macrophages in reactive and malignant lymphoid tissues, showing biological and clinical significance.

摘要

巨噬细胞是弥漫性大 B 细胞淋巴瘤 (DLBCL) 微环境中丰富的免疫细胞。免疫组织化学法估计巨噬细胞在 DLBCL 中的预后意义各不相同,并且不能全面分析巨噬细胞亚型。在这里,我们使用数字空间分析和全转录组分析 CD68+细胞,来描绘反应性淋巴组织 (RLTs) 和 DLBCL 中不同空间龛位的巨噬细胞。我们揭示了 RLT 内巨噬细胞(亮区/暗区、生发中心/滤泡间)之间以及疾病状态(RLTs/DLBCL)之间的转录组差异,然后我们使用这些差异来生成六个空间衍生的巨噬细胞特征 (MacroSigs)。我们继续在巨噬细胞和 DLBCL 单细胞 RNA 测序数据集以及多个 DLBCL 队列的基因表达数据中探究这些 MacroSigs。我们表明,特定的 MacroSigs 与 DLBCL 的细胞起源亚型和总生存率相关。这项研究提供了反应性和恶性淋巴组织中巨噬细胞的空间分辨率全转录组图谱,显示了其生物学和临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/768e66f84717/41467_2024_46220_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/23dd7a2dbf1b/41467_2024_46220_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/6d6a877369c7/41467_2024_46220_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/f34cb065931f/41467_2024_46220_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/a3a9ecddf67d/41467_2024_46220_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/fbecdfb616c6/41467_2024_46220_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/93582d97ff69/41467_2024_46220_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/768e66f84717/41467_2024_46220_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/23dd7a2dbf1b/41467_2024_46220_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/6d6a877369c7/41467_2024_46220_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/f34cb065931f/41467_2024_46220_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/a3a9ecddf67d/41467_2024_46220_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/fbecdfb616c6/41467_2024_46220_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/93582d97ff69/41467_2024_46220_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcc/10923916/768e66f84717/41467_2024_46220_Fig7_HTML.jpg

相似文献

1
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma.空间分辨转录组学揭示弥漫性大 B 细胞淋巴瘤中巨噬细胞的异质性和预后意义。
Nat Commun. 2024 Mar 8;15(1):2113. doi: 10.1038/s41467-024-46220-z.
2
CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment.CCL8 在弥漫性大 B 细胞淋巴瘤 M2 巨噬细胞相互作用中作为一个有前途的预后因素:肿瘤微环境的生物信息学分析。
Front Immunol. 2022 Aug 22;13:950213. doi: 10.3389/fimmu.2022.950213. eCollection 2022.
3
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.CXCR4表达失调促进淋巴瘤细胞存活,并独立预测生发中心B细胞样弥漫性大B细胞淋巴瘤的疾病进展。
Oncotarget. 2015 Mar 20;6(8):5597-614. doi: 10.18632/oncotarget.3343.
4
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.弥漫性大 B 细胞淋巴瘤的肿瘤内异质性涉及诱导多样化的基质-肿瘤界面。
EBioMedicine. 2020 Nov;61:103055. doi: 10.1016/j.ebiom.2020.103055. Epub 2020 Oct 20.
5
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.原发性骨淋巴瘤预后良好,具有独特的基因表达特征,类似于生发中心起源的弥漫性大B细胞淋巴瘤。
Am J Surg Pathol. 2017 Oct;41(10):1309-1321. doi: 10.1097/PAS.0000000000000923.
6
Diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤。
Pathology. 2018 Jan;50(1):74-87. doi: 10.1016/j.pathol.2017.09.006. Epub 2017 Nov 20.
7
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.接受利妥昔单抗-CHOP治疗的弥漫性大B细胞淋巴瘤患者中与MYC重排和Myc过表达相关的临床特征、肿瘤生物学及预后
Mod Pathol. 2015 Dec;28(12):1555-73. doi: 10.1038/modpathol.2015.118. Epub 2015 Nov 6.
8
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.弥漫性大 B 细胞淋巴瘤中肿瘤细胞状态和生态系统的景观。
Cancer Cell. 2021 Oct 11;39(10):1422-1437.e10. doi: 10.1016/j.ccell.2021.08.011. Epub 2021 Sep 30.
9
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.评估CD37 B细胞抗原和起源细胞可显著改善弥漫性大B细胞淋巴瘤的风险预测。
Blood. 2016 Dec 29;128(26):3083-3100. doi: 10.1182/blood-2016-05-715094. Epub 2016 Oct 19.
10
[Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].弥漫性大B细胞淋巴瘤的免疫表型与预后:500例研究
Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):235-9.

引用本文的文献

1
Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model.不可逆电穿孔与同种异体嵌合抗原受体(CAR)T细胞疗法的新型联合方案在临床前人类胰腺癌小鼠模型中可增强治疗效果。
bioRxiv. 2025 Aug 12:2025.08.10.669537. doi: 10.1101/2025.08.10.669537.
2
Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers.犬B细胞淋巴瘤的免疫谱分析揭示了预后标志物的跨物种保守性。
Sci Rep. 2025 Aug 4;15(1):28385. doi: 10.1038/s41598-025-13389-2.
3
Macrophage Membrane-Coated Liposomes Delivering Vonoprazan Disrupt Mitochondrial Oxidative Phosphorylation in Diffuse Large B-Cell Lymphoma.

本文引用的文献

1
An atlas of cells in the human tonsil.人类扁桃体细胞图谱。
Immunity. 2024 Feb 13;57(2):379-399.e18. doi: 10.1016/j.immuni.2024.01.006. Epub 2024 Jan 31.
2
Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle.空间淋巴组织微环境谱的伪时间排序在滤泡外周的未分类弥漫性大 B 细胞淋巴瘤之后。
Front Immunol. 2023 Aug 23;14:1207959. doi: 10.3389/fimmu.2023.1207959. eCollection 2023.
3
High expression of IL4I1 is correlated with poor prognosis and immune infiltration in thyroid cancer.
巨噬细胞膜包被的递送沃克帕唑的脂质体破坏弥漫性大B细胞淋巴瘤中的线粒体氧化磷酸化。
Int J Nanomedicine. 2025 Jun 24;20:8063-8083. doi: 10.2147/IJN.S520567. eCollection 2025.
4
Spatial Transcriptomic Analyses of Spermatogenesis.精子发生的空间转录组学分析
Methods Mol Biol. 2025;2954:49-94. doi: 10.1007/978-1-0716-4698-4_3.
5
VSIG4 as a tumor-associated macrophage marker predicting adverse prognosis in diffuse large B-cell lymphoma.VSIG4作为一种肿瘤相关巨噬细胞标志物可预测弥漫性大B细胞淋巴瘤的不良预后。
Front Immunol. 2025 Jun 5;16:1567035. doi: 10.3389/fimmu.2025.1567035. eCollection 2025.
6
Tumor-Associated Macrophages as Key Modulators of Disease Progression in Diffuse Large B-Cell Lymphoma.肿瘤相关巨噬细胞作为弥漫性大B细胞淋巴瘤疾病进展的关键调节因子
Biomedicines. 2025 May 1;13(5):1099. doi: 10.3390/biomedicines13051099.
7
Single-cell RNA sequencing in diffuse large B-cell lymphoma: tumor heterogeneity, microenvironment, resistance, and prognostic markers.弥漫性大B细胞淋巴瘤中的单细胞RNA测序:肿瘤异质性、微环境、耐药性及预后标志物
Front Oncol. 2025 Apr 9;15:1583250. doi: 10.3389/fonc.2025.1583250. eCollection 2025.
8
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中肿瘤内微生物群驱动的免疫调节及其治疗意义的鉴定
Cancer Immunol Immunother. 2025 Mar 3;74(4):131. doi: 10.1007/s00262-025-03972-x.
9
Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications.医学中的脉冲场消融:不可逆电穿孔和电通透理论与应用
Radiol Oncol. 2025 Feb 27;59(1):1-22. doi: 10.2478/raon-2025-0011. eCollection 2025 Mar 1.
10
Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma.敲除IL4I1会影响巨噬细胞,从而改善CD19嵌合抗原受体T细胞(CAR-T)联合程序性死亡蛋白1(PD-1)抑制剂治疗复发/难治性弥漫性大B细胞淋巴瘤的疗效不佳问题。
J Transl Med. 2025 Jan 22;23(1):105. doi: 10.1186/s12967-024-06028-3.
IL4I1 的高表达与甲状腺癌的不良预后和免疫浸润相关。
BMC Endocr Disord. 2023 Jul 11;23(1):148. doi: 10.1186/s12902-023-01407-1.
4
Inhibitors of Interleukin 4 Induced Protein 1 (IL4I1) as Potential Treatment for Cancer.白细胞介素4诱导蛋白1(IL4I1)抑制剂作为癌症的潜在治疗方法。
ACS Med Chem Lett. 2023 Jan 17;14(2):127-128. doi: 10.1021/acsmedchemlett.2c00525. eCollection 2023 Feb 9.
5
Tingible body macrophages arise from lymph node-resident precursors and uptake B cells by dendrites.有被膜小体的巨噬细胞起源于淋巴结驻留前体细胞,并通过树突摄取 B 细胞。
J Exp Med. 2023 Apr 3;220(4). doi: 10.1084/jem.20222173. Epub 2023 Jan 27.
6
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.弥漫性大 B 细胞淋巴瘤真实世界人群中临床结局的分子决定因素。
Blood. 2023 May 18;141(20):2493-2507. doi: 10.1182/blood.2022018248.
7
Transcriptional and Immune Landscape of Cardiac Sarcoidosis.心脏结节病的转录和免疫景观。
Circ Res. 2022 Sep 30;131(8):654-669. doi: 10.1161/CIRCRESAHA.121.320449. Epub 2022 Sep 16.
8
Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling.利用数字空间分析技术在人体和小鼠组织中进行空间分辨的全转录组分析。
Genome Res. 2022 Oct;32(10):1892-1905. doi: 10.1101/gr.276206.121. Epub 2022 Sep 13.
9
Targeting macrophages in hematological malignancies: recent advances and future directions.靶向血液系统恶性肿瘤中的巨噬细胞:最新进展与未来方向。
J Hematol Oncol. 2022 Aug 17;15(1):110. doi: 10.1186/s13045-022-01328-x.
10
Macrophages as tools and targets in cancer therapy.巨噬细胞作为癌症治疗的工具和靶点。
Nat Rev Drug Discov. 2022 Nov;21(11):799-820. doi: 10.1038/s41573-022-00520-5. Epub 2022 Aug 16.